Top-News

Lonza Group Unsp. ADR 1/10 Aktie News

Aktie
WKN:  A0YF75 ISIN:  US54338V1017 US-Symbol:  LZAGY Land:  Schweiz
67,52 $
-0,47 $
-0,69%
57,988 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
99,83%
KGV
59,83
Dividende
0,18 $
Dividendenrendite
0,26%
Index-Zuordnung
-

Lonza Group Unsp. ADR 1/10 News

09.01.25 - PR Newswire
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix's ADC technology
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix's ADC technology PR Newswire
09.01.25 - PR Newswire
Synaffix and Mitsubishi Tanabe Pharma Sign License Agreement for ADC Technology
Synaffix and Mitsubishi Tanabe Pharma Sign License Agreement for ADC Technology PR Newswire
09.01.25 - PR Newswire
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix's ADC technology
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix's ADC technology PR Newswire
09.01.25 - PR Newswire
Synaffix and Mitsubishi Tanabe Pharma Sign License Agreement for ADC Technology
Synaffix and Mitsubishi Tanabe Pharma Sign License Agreement for ADC Technology PR Newswire
12.12.24 - PR Newswire
Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline Expansion
Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline Expansion PR Newswire
12.12.24 - PR Newswire
Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors
Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors PR Newswire
12.12.24 - PR Newswire
Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline Expansion
Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline Expansion PR Newswire

Newssuche

Videos

newspaper
18:20 Uhr
Master the Trading!
In diesem Trading-​Webinar haben wir von A bis Z den Aufbau professionellen Tradings thematisiert und ... Mehr »